# Andreas Nilsson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andreas-nilsson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 302 |
| Field | Diabetes Treatment and Management |
| h-index | 9 |
| i10-index | 9 |
| Last Known Institution | Swedish Institute for Health Economics |
| OpenAlex ID | https://openalex.org/A5003618535 |
| ORCID iD | 0000-0002-4604-7766 |
| Works | 38 |

## Researcher papers

- [Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge](https://scholariq.org/papers/evaluating-the-ability-of-economic-models-of-diabetes-to-simulate-new/)
- [Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)](https://scholariq.org/papers/validation-of-the-economic-and-health-outcomes-model-of-type-2-diabetes-mellitus/)
- [Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model](https://scholariq.org/papers/cost-effectiveness-of-canagliflozin-added-to-standard-of-care-for-treating/)
- [Multivariate Prediction Equations for HbA 1c Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus: Informing Economic Modeling](https://scholariq.org/papers/multivariate-prediction-equations-for-hba-1c-lowering-weight-change-and/)
- [Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM](https://scholariq.org/papers/comparing-the-cohort-and-micro-simulation-modeling-approaches-in-cost/)
- [Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial Data](https://scholariq.org/papers/development-and-internal-validation-of-a-discrete-event-simulation-model-of/)
- [Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature Review](https://scholariq.org/papers/challenges-and-opportunities-associated-with-incorporating-new-evidence-of-drug/)
- [Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting](https://scholariq.org/papers/long-term-cost-effectiveness-of-oral-semaglutide-versus-empagliflozin-and/)
- [Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting](https://scholariq.org/papers/cost-effectiveness-of-once-weekly-semaglutide-1-mg-versus-canagliflozin-300-mg/)
- [Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium](https://scholariq.org/papers/health-economic-modelling-of-diabetic-kidney-disease-in-patients-with-type-2/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)

## Researcher university

- [Swedish Institute for Health Economics](https://scholariq.org/institutions/swedish-institute-for-health-economics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.